Return to homepagePandemic Pact

Opioid Use Disorder Care during COVID-19 Disruptions

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:2 publications

Grant number: 173111

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $152,851.59

  • Funder

    Canadian Institutes of Health Research (CIHR)

  • Principal Investigator

    Patrick McLane

  • Research Location

    Canada

  • Lead Research Institution

    University of Alberta

  • Research Priority Alignment

    N/A

  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    Digital Health

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Minority communities unspecified

  • Occupations of Interest

    Unspecified

Abstract

COVID-19 is disrupting opioid use disorder treatment, and the impacts of these disruptions are unknown. Community addictions clinics have switched to virtual care, decreased their opening hours, or closed. At the same time, opioid overdoses in Alberta and British Columbia have increased. It is currently not known whether patients are being supported through adjusted opioid use disorder care, or whether they are going undertreated. This project will combine review of opioid addiction clinic and emergency department data to profile the impact of COVID-19 on opioid use disorder treatment. Crucially, we will assess impacts of changes in opioid use disorder treatment for First Nations members, in partnership with the Blackfoot Confederacy.

2 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

How are social stressors at work related to well-being and health? A systematic review and meta-analysis.

Quenching of Unincorporated Amplification Signal Reporters in Reverse-Transcription Loop-Mediated Isothermal Amplification Enabling Bright, Single-Step, Closed-Tube, and Multiplexed Detection of RNA Viruses.